市場調査レポート
商品コード
1059347

ゲノム編集の世界市場:2028年までの予測 - 分析 - 技術別、用途別、エンドユーザー別

Genome Editing Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Technology, Application, and End User

出版日: | 発行: The Insight Partners | ページ情報: 英文 176 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.25円
ゲノム編集の世界市場:2028年までの予測 - 分析 - 技術別、用途別、エンドユーザー別
出版日: 2022年01月14日
発行: The Insight Partners
ページ情報: 英文 176 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のゲノム編集の市場規模は、2021年に51億9,940万米ドルとなりました。同市場は、2021年~2028年にかけて18.4%のCAGRで拡大し、2028年には169億8,669万米ドルに達すると予測されています。

当レポートでは、世界のゲノム編集市場について調査し、市場の概要とともに、技術別、用途別、エンドユーザー別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 イントロダクション

第2章 ゲノム編集市場-重要なポイント

第3章 調査手法

第4章 ゲノム編集市場-市場情勢の展望

  • 概要
  • PEST分析
  • 専門家の見解

第5章 ゲノム編集市場-主要な市場力学

  • 市場の促進要因
  • 市場の抑制要因
  • 市場の機会
  • 今後の動向
  • 影響分析

第6章 ゲノム編集市場-世界の分析

  • 世界のゲノム編集市場の収益予測と分析
  • 世界のゲノム編集市場、地域別-予測と分析
  • 主要企業の市場における位置づけ

第7章 世界のゲノム編集市場の収益と2028年までの予測-技術別

  • 概要
  • 世界のゲノム編集市場、技術別、2021年および2028年(%)
  • CRISPR
  • TALEN
  • アンチセンス
  • その他

第8章 ゲノム編集市場の収益と2028年までの予測-用途別

  • 概要
  • 世界のゲノム編集市場シェア、用途別-2021年および2028年(%)
  • 細胞株工学
  • 遺伝子工学
  • 診断アプリケーション
  • 創薬
  • その他

第9章 ゲノム編集市場の収益と2028年までの予測-エンドユーザー別

  • 概要
  • 世界のゲノム編集市場シェア、エンドユーザー別-2021年および2028年(%)
  • 製薬会社およびバイオテクノロジー企業
  • CRO
  • 学術研究機関

第10章 ゲノム編集市場の収益と2028年までの予測-地域分析

  • 北米:ゲノム編集市場
  • 欧州:ゲノム編集市場
  • アジア太平洋:ゲノム編集市場の収益と2028年までの予測
  • 中東・アフリカ:ゲノム編集市場の収益と2028年までの予測
  • 中南米:ゲノム編集市場の収益と2028年までの予測

第11章 ゲノム編集市場に対するCOVID-19パンデミックの影響

  • 北米:COVID-19パンデミックの影響評価
  • 欧州:COVID-19パンデミックの影響評価
  • アジア太平洋:COVID-19パンデミックの影響評価
  • 中東・アフリカ:COVID-19パンデミックの影響評価
  • 中南米:COVID-19パンデミックの影響評価

第12章 ゲノム編集市場-業界情勢の展望

  • 概要
  • 市場参入企業による成長戦略(%)
  • 有機的開発
  • 無機的開発

第13章 企業プロファイル

  • THERMO FISHER SCIENTIFIC INC.
  • MERCK KGaA
  • Lonza
  • Horizon Discovery Group plc.
  • Integrated DNA Technologies
  • GenScript
  • New England Biolabs
  • Eurofins Scientific
  • CRISPR Therapeutics
  • Editas Medicine

第14章 付録

図表

List Of Tables

  • Table 1. North America Genome Editing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
  • Table 2. North America Genome Editing Market, by Applications- Revenue and Forecast to 2028 (US$ Million)
  • Table 3. North America Genome Editing Market, End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 4. US Genome Editing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. US Genome Editing Market, by Applications- Revenue and Forecast to 2028 (US$ Million)
  • Table 6. US Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. Canada: Genome Editing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. Canada Genome Editing Market, by Applications- Revenue and Forecast to 2028 (US$ Million)
  • Table 9. Canada Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. Mexico: Genome Editing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. Mexico Genome Editing Market, by Applications- Revenue and Forecast to 2028 (US$ Million)
  • Table 12. Mexico Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. Europe: Genome Editing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
  • Table 14. Europe: Genome Editing Market, by Applications- Revenue and Forecast to 2028 (US$ Million)
  • Table 15. Europe: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 16. Germany: Genome Editing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
  • Table 17. Germany: Genome Editing Market, by Applications- Revenue and Forecast to 2028 (US$ Million)
  • Table 18. Germany: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 19. France: Genome Editing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
  • Table 20. France: Genome Editing Market, by Applications- Revenue and Forecast to 2028 (US$ Million)
  • Table 21. France: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 22. UK: Genome Editing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
  • Table 23. UK: Genome Editing Market, by Applications- Revenue and Forecast to 2028 (US$ Million)
  • Table 24. UK: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 25. Italy: Genome Editing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
  • Table 26. Italy: Genome Editing Market, by Applications- Revenue and Forecast to 2028 (US$ Million)
  • Table 27. Italy: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 28. Spain: Genome Editing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
  • Table 29. Spain: Genome Editing Market, by Applications- Revenue and Forecast to 2028 (US$ Million)
  • Table 30. Spain: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 31. Rest of Europe: Genome Editing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
  • Table 32. Rest of Europe: Genome Editing Market, by Applications- Revenue and Forecast to 2028 (US$ Million)
  • Table 33. Rest of Europe: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 34. Asia Pacific: Genome Editing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
  • Table 35. Asia Pacific: Genome Editing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 36. Asia Pacific: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 37. China: Genome Editing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
  • Table 38. China: Genome Editing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 39. China: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 40. Japan: Genome Editing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
  • Table 41. Japan: Genome Editing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 42. Japan: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 43. India: Genome Editing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
  • Table 44. India: Genome Editing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 45. India: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 46. South Korea: Genome Editing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
  • Table 47. South Korea: Genome Editing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 48. South Korea: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 49. Australia: Genome Editing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
  • Table 50. Australia: Genome Editing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 51. Australia: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 52. Rest of Asia Pacific: Genome Editing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
  • Table 53. Rest of Asia Pacific: Genome Editing Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 54. Rest of Asia Pacific: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 55. Middle East & Africa: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
  • Table 56. Middle East & Africa: Genome Editing Market, by Applications, Revenue and Forecast to 2028 (US$ Million)
  • Table 57. Middle East & Africa: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 58. UAE: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
  • Table 59. UAE: Genome Editing Market, by Applications, Revenue and Forecast to 2028 (US$ Million)
  • Table 60. UAE: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 61. Saudi Arabia: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
  • Table 62. Saudi Arabia: Genome Editing Market, by Applications, Revenue and Forecast to 2028 (US$ Million)
  • Table 63. Saudi Arabia: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 64. South Africa: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
  • Table 65. South Africa: Genome Editing Market, by Applications, Revenue and Forecast to 2028 (US$ Million)
  • Table 66. South Africa: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 67. Rest of Middle East & Africa: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
  • Table 68. Rest of Middle East & Africa: Genome Editing Market, by Applications, Revenue and Forecast to 2028 (US$ Million)
  • Table 69. Rest of Middle East and Africa: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 70. South and Central America: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
  • Table 71. South and Central America: Genome Editing Market, by Applications, Revenue and Forecast to 2028 (US$ Million)
  • Table 72. South and Central America: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 73. Argentina: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
  • Table 74. Argentina: Genome Editing Market, by Applications, Revenue and Forecast to 2028 (US$ Million)
  • Table 75. Argentina: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 76. Brazil: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
  • Table 77. Brazil: Genome Editing Market, by Applications, Revenue and Forecast to 2028 (US$ Million)
  • Table 78. Brazil: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 79. Rest of South & Central America: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
  • Table 80. Rest of South & Central America: Genome Editing Market, by Applications, Revenue and Forecast to 2028 (US$ Million)
  • Table 81. Rest of South and Central America: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 82. Organic Developments Done by Companies
  • Table 83. Inorganic Developments Done by Companies
  • Table 84. Glossary of Terms, Genome Editing Market

List Of Figures

  • Figure 1. Genome Editing Market Segmentation
  • Figure 2. Cell Therapy Bioprocessing Segmentation, By Region
  • Figure 3. Global Genome Editing Market Overview
  • Figure 4. CRISPR Held Largest Share of Technology Segment in Genome Editing Market
  • Figure 5. Asia Pacific to Show Remarkable Growth During Forecast Period
  • Figure 6. Genome Editing Market, by Geography (US$ Million)
  • Figure 7. Global Genome Editing Market- Leading Country Markets (US$ Million)
  • Figure 8. Global Genome Editing Market, Industry Landscape
  • Figure 9. North America: PEST Analysis
  • Figure 10. Europe: PEST Analysis
  • Figure 11. Asia Pacific: PEST Analysis
  • Figure 12. Middle East and Africa: PEST Analysis
  • Figure 13. South and Central America: PEST Analysis
  • Figure 14. Expert Opinion
  • Figure 15. Genome Editing Market Impact Analysis of Drivers and Restraints
  • Figure 16. Global Genome Editing Market- Revenue Forecast and Analysis - 2020-2028
  • Figure 17. Global Genome Editing Market- By Geography Forecast and Analysis - 2020-2028
  • Figure 18. Market Positioning of Key Players in Global Genome Editing Market
  • Figure 19. Global Genome Editing Market, by Technology, 2021 & 2028 (%)
  • Figure 20. CRISPR: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. TALEN: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. Antisense: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. Others: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 24. Global Genome Editing Market Share, by Application - 2021 & 2028 (%)
  • Figure 25. Cell Line Engineering: Genome Editing Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 26. Genetic Engineering: Genome Editing Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 27. Diagnostic Applications: Genome Editing Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 28. Drug Discovery: Genome Editing Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 29. Others: Genome Editing Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 30. Global Genome Editing Market Share by End User - 2021 & 2028 (%)
  • Figure 31. Pharmaceutical and Biotechnology Companies: Genome Editing Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 32. Clinical Research Organizations: Genome Editing Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 33. Academic and Research Institutes: Genome Editing Market Revenue and Forecasts To 2028 (US$ Million)
  • Figure 34. North America: Genome Editing Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 35. North America Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 36. North America: Genome Editing Market, by Country, 2021 & 2028 (%)
  • Figure 37. US: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 38. Canada: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 39. Mexico: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 40. Europe: Genome Editing Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 41. Europe: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 42. Europe: Genome Editing Market, by Country, 2021 & 2028 (%)
  • Figure 43. Germany: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 44. France: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 45. UK: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 46. Italy: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 47. Spain: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 48. Rest of Europe: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 49. Asia Pacific: Genome Editing Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 50. Asia Pacific: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 51. Asia Pacific: Genome Editing Market, by Country, 2021 & 2028 (%)
  • Figure 52. China: Genome Editing Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 53. Japan: Genome Editing Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 54. India: Genome Editing Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 55. South Korea: Genome Editing Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 56. Australia: Genome Editing Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 57. Rest of Asia Pacific: Genome Editing Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 58. Middle East & Africa Genome Editing Market Revenue Overview, by Country, 2021 (US$ Million)
  • Figure 59. Middle East & Africa Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 60. Middle East & Africa: Genome Editing Market, by Country, 2021 & 2028 (%)
  • Figure 61. UAE: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 62. Saudi Arabia: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 63. South Africa: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 64. Rest of Middle East and Africa: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 65. South and Central America: Genome Editing Market Revenue Overview, by Country, 2021 (US$ Million)
  • Figure 66. South and Central America: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 67. South and Central America: Genome Editing Market, by Country, 2021 & 2028 (%)
  • Figure 68. Argentina: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 69. Brazil: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 70. Rest of South and Central America: Genome Editing Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 71. Impact of COVID-19 Pandemic in North American Country Markets
  • Figure 72. Impact of COVID-19 Pandemic in European Country Markets
  • Figure 73. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
  • Figure 74. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
  • Figure 75. Impact Of COVID-19 Pandemic in South and Central America Africa Country Markets
  • Figure 76. Growth Strategies Done by the Companies in the Market, (%)
目次
Product Code: TIPHE100000853

The genome editing market is projected to reach US$ 16,986.69 million by 2028 from US$ 5,199.40 million in 2021; it is expected to grow at a CAGR of 18.4% from 2021 to 2028.

Over the past few years, advances in genome editing technologies have been making constant headlines. Genome editing technologies can alter biological research and significantly impact human health, food security, and environmental sustainability since they are precise, relatively inexpensive, easy to use, and remarkably powerful. The advances in genome editing can be traced back to quiet beginnings in the 1990s. The introduction of CRISPR-Cas9-a genome-editing tool that can be used to make precise and targeted changes in the DNA sequence with ease-is mainly responsible for the recent rise in the amount and scope of applications of genome editing technologies. The CRISPR platform's ease of use, as compared to previous technologies, has resulted in its widespread adoption and application. Genome editing could have a favorable impact on sustainable development, environmental management, food security, and the introduction of affordable diagnostics and therapies for various diseases due to these advancements.

A team from MIT and Harvard's Broad Institute has developed a novel CRISPR genome-editing technique that has the potential to fix up to 89% of disease-causing genetic abnormalities. CRISPR-Cas9 and reverse transcriptase, two of the most significant proteins in molecular biology, have been merged into a single machine by researchers. Prime editing is a method that can alter human cells directly in a precise, efficient, and highly versatile manner. They have also developed a CRISPR RNA-cutting enzyme into an antiviral agent that can be programmed to detect and eliminate RNA-based viruses in human cells. The Cas13 enzyme has previously been used to cut and alter human RNA and as a diagnostic approach for detecting the presence of viruses, bacteria, and other targets. This is one of the first studies to use Cas13, or any CRISPR system, as an antiviral in human cells in culture.

Recognizing the potential of genome editing techniques for studying and manipulating the genome., the Department of Biotechnology (DBT), Govt. of India has been fostering research and innovation in genome engineering technologies and applications to make them more accessible and inexpensive for research and development ( R&D). Through focused calls for proposals in different areas such as the development of new methods, tools, processes, and platforms for genome editing, improvement of existing genome-editing methods, and novel applications of genome editing technologies in agriculture, bioenergy, environmental research, and human health, efforts have been made to encourage R&D programs in emerging genome engineering technologies and their applications.

World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), and National Health and Wellness Centers for Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC) are among the primary and secondary sources referred to while preparing the report on the genome editing market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the genome editing market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global genome editing market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Genome Editing Market- By Technology
    • 1.3.2 Genome Editing Market- By Application
    • 1.3.3 Genome Editing Market- By End User
    • 1.3.4 Genome Editing Market- By Geography

2. Genome Editing Market- Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Genome Editing Market- Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
    • 4.2.2 Europe PEST Analysis
    • 4.2.3 Asia Pacific PEST Analysis
    • 4.2.4 Middle East and Africa PEST Analysis
    • 4.2.5 South and Central America PEST Analysis
  • 4.3 Expert Opinion

5. Genome Editing Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rise in Prevalence of Cancer and Other Genetic Disorders
    • 5.1.2 Continuous Technological Advancements in Gene-Editing Tools
  • 5.2 Market Restraints
    • 5.2.1 High Cost of Genomic Equipment
  • 5.3 Market Opportunities
    • 5.3.1 Developing Biotechnology Industry in Emerging Regions
  • 5.4 Future Trends
    • 5.4.1 Technological Innovations
  • 5.5 Impact Analysis

6. Genome Editing Market- Global Analysis

  • 6.1 Global Genome Editing Market Revenue Forecast and Analysis
  • 6.2 Global Genome Editing Market, By Geography - Forecast and Analysis
  • 6.3 Market Positioning of Key Players

7. Global Genome Editing Market Revenue and Forecasts To 2028- by Technology

  • 7.1 Overview
  • 7.2 Global Genome Editing Market, By Technology, 2021 & 2028 (%)
  • 7.3 Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
    • 7.3.1 Overview
    • 7.3.2 CRISPR: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
  • 7.4 TALEN
    • 7.4.1 Overview
    • 7.4.2 TALEN: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Antisense
    • 7.5.1 Overview
    • 7.5.2 Antisense: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 Others: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

8. Genome Editing Market Revenue and Forecasts To 2028 - Application

  • 8.1 Overview
  • 8.2 Global Genome Editing Market Share, By Application - 2021 & 2028 (%)
  • 8.3 Cell Line Engineering
    • 8.3.1 Overview
    • 8.3.2 Cell Line Engineering: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Genetic Engineering
    • 8.4.1 Overview
    • 8.4.2 Genetic Engineering: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
  • 8.5 Diagnostic Applications
    • 8.5.1 Overview
    • 8.5.2 Diagnostic Applications: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
  • 8.6 Drug Discovery
    • 8.6.1 Overview
    • 8.6.2 Drug Discovery: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
  • 8.7 Others
    • 8.7.1 Overview
    • 8.7.2 Others: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

9. Genome Editing Market Revenue and Forecasts To 2028 - End User

  • 9.1 Overview
  • 9.2 Global Genome Editing Market Share by End User - 2021 & 2028 (%)
  • 9.3 Pharmaceutical and Biotechnology Companies
    • 9.3.1 Overview
    • 9.3.2 Pharmaceutical and Biotechnology Companies: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Clinical Research Organizations (CRO's)
    • 9.4.1 Overview
    • 9.4.2 Clinical Research Organizations: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Academic and Research Institutes
    • 9.5.1 Overview
    • 9.5.2 Academic and Research Institutes: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

10. Genome Editing Market Revenue and Forecasts to 2028 - Geographical Analysis

  • 10.1 North America: Genome Editing Market
    • 10.1.1 Overview
    • 10.1.2 North America: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.1.3 North America: Genome Editing Market, by Technology, 2019-2028 (US$ Million)
    • 10.1.4 North America: Genome Editing Market, by Applications, 2019-2028 (US$ Million)
    • 10.1.5 North America: Genome Editing Market, End User, 2019-2028 (US$ Million)
    • 10.1.6 North America: Genome Editing Market, by Country, 2021 & 2028 (%)
      • 10.1.6.1 US: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.1.1 Overview
        • 10.1.6.1.2 US: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.1.3 US: Genome Editing Market, by Technology, 2019-2028 (US$ Million)
        • 10.1.6.1.4 US: Genome Editing Market, by Applications, 2019-2028 (US$ Million)
        • 10.1.6.1.5 US: Genome Editing Market, End User, 2019-2028 (US$ Million)
      • 10.1.6.2 Canada: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.2.1 Overview
        • 10.1.6.2.2 Canada: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.2.3 Canada: Genome Editing Market, by Technology, 2019-2028 (US$ Million)
        • 10.1.6.2.4 Canada: Genome Editing Market, by Applications, 2019-2028 (US$ Million)
        • 10.1.6.2.5 Canada: Genome Editing Market, End User, 2019-2028 (US$ Million)
      • 10.1.6.3 Mexico: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.3.1 Overview
        • 10.1.6.3.2 Mexico: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.3.3 Mexico: Genome Editing Market, by Technology, 2019-2028 (US$ Million)
        • 10.1.6.3.4 Mexico: Genome Editing Market, by Applications, 2019-2028 (US$ Million)
        • 10.1.6.3.5 Mexico: Genome Editing Market, End User, 2019-2028 (US$ Million)
  • 10.2 Europe: Genome Editing Market
    • 10.2.1 Overview
    • 10.2.2 Europe: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.2.3 Europe: Genome Editing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
    • 10.2.4 Europe: Genome Editing Market, by Applications- Revenue and Forecast to 2028 (US$ Million)
      • 10.2.4.1 Europe: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
    • 10.2.5 Europe: Genome Editing Market, by Country, 2021 & 2028 (%)
      • 10.2.5.1 Germany: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.5.1.1 Overview
        • 10.2.5.1.2 Germany: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.5.1.3 Germany: Genome Editing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.5.1.4 Germany: Genome Editing Market, by Applications- Revenue and Forecast to 2028 (US$ Million)
        • 10.2.5.1.5 Germany: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.5.2 France: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.5.2.1 Overview
        • 10.2.5.2.2 France: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.5.2.3 France: Genome Editing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.5.2.4 France: Genome Editing Market, by Applications- Revenue and Forecast to 2028 (US$ Million)
        • 10.2.5.2.5 France: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.5.3 UK: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.5.3.1 Overview
        • 10.2.5.3.2 UK: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.5.3.3 UK: Genome Editing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.5.3.4 UK: Genome Editing Market, by Applications- Revenue and Forecast to 2028 (US$ Million)
        • 10.2.5.3.5 UK: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.5.4 Italy: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.5.4.1 Overview
        • 10.2.5.4.2 Italy: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.5.4.3 Italy: Genome Editing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.5.4.4 Italy: Genome Editing Market, by Applications- Revenue and Forecast to 2028 (US$ Million)
        • 10.2.5.4.5 Italy: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.5.5 Spain: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.5.5.1 Overview
        • 10.2.5.5.2 Spain: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.5.5.3 Spain: Genome Editing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.5.5.4 Spain: Genome Editing Market, by Applications- Revenue and Forecast to 2028 (US$ Million)
        • 10.2.5.5.5 Spain: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 10.2.5.6 Rest of Europe: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.5.6.1 Overview
        • 10.2.5.6.2 Rest of Europe: Genome Editing Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.5.6.3 Rest of Europe: Genome Editing Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.5.6.4 Rest of Europe: Genome Editing Market, by Applications- Revenue and Forecast to 2028 (US$ Million)
        • 10.2.5.6.5 Rest of Europe: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • 10.3 Asia Pacific: Genome Editing Market Revenue and Forecast to 2028
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific: Genome Editing Market- Revenue and Forecast to 2028 (US$ Million)
    • 10.3.3 Asia Pacific: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
    • 10.3.4 Asia Pacific: Genome Editing Market, by Application, Revenue and Forecast to 2028 (US$ Million)
    • 10.3.5 Asia Pacific: Genome Editing Market, by End User, Revenue and Forecast to 2028 (US$ Million)
    • 10.3.6 Asia Pacific: Genome Editing Market, by Country, 2021 & 2028 (%)
      • 10.3.6.1 China: Genome Editing Market- Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.1.1 Overview
        • 10.3.6.1.2 China: Genome Editing Market- Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.1.3 China: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.1.4 China: Genome Editing Market, by Application, Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.1.5 China: Genome Editing Market, by End User, Revenue and Forecast to 2028 (US$ Million)
      • 10.3.6.2 Japan: Genome Editing Market- Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.2.1 Overview
        • 10.3.6.2.2 Japan: Genome Editing Market- Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.2.3 Japan: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.2.4 Japan: Genome Editing Market, by Application, Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.2.5 Japan: Genome Editing Market, by End User, Revenue and Forecast to 2028 (US$ Million)
      • 10.3.6.3 India: Genome Editing Market- Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.3.1 Overview
        • 10.3.6.3.2 India: Genome Editing Market- Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.3.3 India: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.3.4 India: Genome Editing Market, by Application, Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.3.5 India: Genome Editing Market, by End User, Revenue and Forecast to 2028 (US$ Million)
      • 10.3.6.4 South Korea: Genome Editing Market- Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.4.1 Overview
        • 10.3.6.4.2 South Korea: Genome Editing Market- Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.4.3 South Korea: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.4.4 South Korea: Genome Editing Market, by Application, Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.4.5 South Korea: Genome Editing Market, by End User, Revenue and Forecast to 2028 (US$ Million)
      • 10.3.6.5 Australia: Genome Editing Market- Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.5.1 Overview
        • 10.3.6.5.2 Australia: Genome Editing Market- Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.5.3 Australia: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.5.4 Australia: Genome Editing Market, by Application, Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.5.5 Australia: Genome Editing Market, by End User, Revenue and Forecast to 2028 (US$ Million)
      • 10.3.6.6 Rest of Asia Pacific: Genome Editing Market- Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.6.1 Overview
        • 10.3.6.6.2 Rest of Asia Pacific: Genome Editing Market- Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.6.3 Rest of Asia Pacific: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.6.4 Rest of Asia Pacific: Genome Editing Market, by Application, Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.6.5 Rest of Asia Pacific: Genome Editing Market, by End User, Revenue and Forecast to 2028 (US$ Million)
  • 10.4 Middle East & Africa Genome Editing Market Revenue and Forecasts To 2028
    • 10.4.1 Overview
    • 10.4.2 Middle East & Africa Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
    • 10.4.3 Middle East & Africa: Genome Editing Market Revenue and Forecast to 2028, Technology (US$ Million)
    • 10.4.4 Middle East & Africa: Genome Editing Market, by Applications, Revenue and Forecast to 2028 (US$ Million)
      • 10.4.4.1 Middle East & Africa: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
    • 10.4.5 Middle East & Africa: Genome Editing Market, by Country, 2021 & 2028 (%)
      • 10.4.5.1 UAE: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
        • 10.4.5.1.1 Overview
        • 10.4.5.1.2 UAE: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
        • 10.4.5.1.3 UAE: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
        • 10.4.5.1.4 UAE: Genome Editing Market, by Applications, Revenue and Forecast To 2028 (US$ Million)
        • 10.4.5.1.5 UAE: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 10.4.5.2 Saudi Arabia: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
        • 10.4.5.2.1 Overview
        • 10.4.5.2.2 Saudi Arabia: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
        • 10.4.5.2.3 Saudi Arabia: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
        • 10.4.5.2.4 Saudi Arabia: Genome Editing Market, by Applications, Revenue and Forecast To 2028 (US$ Million)
        • 10.4.5.2.5 Saudi Arabia: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 10.4.5.3 South Africa: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
        • 10.4.5.3.1 Overview
        • 10.4.5.3.2 South Africa: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
        • 10.4.5.3.3 South Africa: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
        • 10.4.5.3.4 South Africa: Genome Editing Market, by Applications, Revenue and Forecast To 2028 (US$ Million)
        • 10.4.5.3.5 South Africa: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 10.4.5.4 Rest of Middle East and Africa: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
        • 10.4.5.4.1 Overview
        • 10.4.5.4.2 Rest of Middle East and Africa: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
        • 10.4.5.4.3 Rest of Middle East & Africa: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
        • 10.4.5.4.4 Rest of Middle East & Africa: Genome Editing Market, by Applications, Revenue and Forecast To 2028 (US$ Million)
        • 10.4.5.4.5 Rest of Middle East and Africa: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • 10.5 South and Central America: Genome Editing Market Revenue and Forecast To 2028
    • 10.5.1 Overview
    • 10.5.2 South and Central America: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
    • 10.5.3 South and Central America: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
    • 10.5.4 South and Central America: Genome Editing Market, by Applications, Revenue and Forecast to 2028 (US$ Million)
    • 10.5.5 South and Central America: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
    • 10.5.6 South and Central America: Genome Editing Market, by Country, 2021 & 2028 (%)
      • 10.5.6.1 Argentina: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.1.1 Overview
        • 10.5.6.1.2 Argentina: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.1.3 Argentina: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.1.4 Argentina: Genome Editing Market, by Applications, Revenue and Forecast To 2028 (US$ Million)
        • 10.5.6.1.5 Argentina: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 10.5.6.2 Brazil: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.2.1 Overview
        • 10.5.6.2.2 Brazil: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.2.3 Brazil: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.2.4 Brazil: Genome Editing Market, by Applications, Revenue and Forecast To 2028 (US$ Million)
        • 10.5.6.2.5 Brazil: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 10.5.6.3 Rest of South and Central America: Genome Editing Market- Revenue and Forecast to 2028 (USD Mn)
        • 10.5.6.3.1 Overview
        • 10.5.6.3.2 Rest of South and Central America: Genome Editing Market- Revenue and Forecast to 2028 (USD Mn)
        • 10.5.6.3.3 Rest of South & Central America: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.3.4 Rest of South & Central America: Genome Editing Market, by Applications, Revenue and Forecast To 2028 (US$ Million)
        • 10.5.6.3.5 Rest of South and Central America: Genome Editing Market, by End User - Revenue and Forecast to 2028 (US$ Million)

11. Impact Of COVID-19 Pandemic on Genome Editing Market

  • 11.1 North America: Impact Assessment of COVID-19 Pandemic
  • 11.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
  • 11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
  • 11.5 South and Central America: Impact Assessment of COVID-19 Pandemic

12. Genome Editing Market-Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies Done by the Companies in the Market, (%)
  • 12.3 Organic Developments
    • 12.3.1 Overview
  • 12.4 Inorganic Developments
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 THERMO FISHER SCIENTIFIC INC.
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 MERCK KGaA
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Lonza
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Horizon Discovery Group plc.
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Integrated DNA Technologies
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 GenScript
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 New England Biolabs
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Eurofins Scientific
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 CRISPR Therapeutics
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Editas Medicine
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 Glossary of Terms